HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical and immunological risk factors for severe disease in Japanese encephalitis.

Abstract
Eighty-five paediatric patients in Thailand with acute Japanese encephalitis (JE) were studied in 1987-99 to determine risk factors present at hospital admission which were associated with severe disease. On univariate analysis, the following factors on admission were significantly associated with the combined end-point of death or a severe neurological deficit: depressed level of consciousness, elevated concentration of cerebrospinal fluid (CSF) protein, low levels of serum and CSF IgG antibody against Japanese encephalitis virus (JEV), low level of serum IgM antibody against JEV, and a serological response consistent with primary flavivirus infection. On multivariate analysis, an initial serum anti-JEV IgM < 150 U and the absence of a prior flavivirus infection, presumably dengue, remained independent risk factors for death or a severe neurological deficit. The ability to mount an early and vigorous JEV-reactive antibody response is associated with a better outcome from acute JE. An anamnestic, anti-flavivirus, immune response induced by a prior dengue virus infection can be an important means of providing this protection.
AuthorsDaniel H Libraty, Ananda Nisalak, Timothy P Endy, Saroj Suntayakorn, David W Vaughn, Bruce L Innis
JournalTransactions of the Royal Society of Tropical Medicine and Hygiene (Trans R Soc Trop Med Hyg) 2002 Mar-Apr Vol. 96 Issue 2 Pg. 173-8 ISSN: 0035-9203 [Print] England
PMID12055808 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Viral
  • Immunoglobulin G
Topics
  • Antibodies, Viral (immunology)
  • Child
  • Child, Preschool
  • Encephalitis Virus, Japanese (immunology)
  • Encephalitis, Japanese (immunology)
  • Female
  • Humans
  • Immunoglobulin G (analysis)
  • Infant
  • Infant, Newborn
  • Male
  • Multivariate Analysis
  • Prognosis
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: